Russia Moves To Formalize EAEU Medical Device Registration 2026: Roszdravnadzor Administrative Regulation And Market Access Guide

What the 2026 Russian Draft Administrative Regulation Means for Medical Device Manufacturers, Authorized Representatives and EAEU Market Entry

Russia is taking another step toward formalizing the administration of medical device registration under the Eurasian Economic Union (EAEU) framework.

On 20 April 2026, the Russian Federal Service for Surveillance in Healthcare (Roszdravnadzor) prepared a draft administrative regulation covering the state service for registration of medical devices under the EAEU registration rules established by EEC Council Decision No. 46 of 12 February 2016. The draft sets out the procedure and standards for the state service administered by Roszdravnadzor.

Importantly, the proposal does not create a separate Russian EAEU registration pathway. Instead, it provides a more detailed Russian administrative framework for implementing the existing EAEU registration and examination system.

For manufacturers, authorized representatives and companies planning EAEU market access, the development provides greater visibility into how applications, registration certificates, dossier changes and related administrative procedures are handled in Russia.

Companies preparing EAEU submissions should therefore review their regulatory strategy, applicant arrangements, technical documentation, quality management evidence and Russian procedural requirements.

What Is Changing?

The draft administrative regulation is intended to establish the procedure and standard for Roszdravnadzor's provision of the state service for EAEU medical device registration.

The service is intended for:

• Medical device manufacturers
• Authorized representatives
• Manufacturers established outside the EAEU
• Companies preparing registration applications through Russia as the relevant regulatory jurisdiction

Under the draft, Roszdravnadzor would remain the authority providing the service, while the substantive registration and examination requirements continue to derive from EAEU Decision No. 46.

The distinction is important. Companies should not interpret the draft as replacing the EAEU regulatory framework with a purely Russian registration system.

EAEU Registration Remains the Regulatory Framework

The EAEU medical device system is based on common Union-level rules concerning registration, safety, quality and performance.

Decision No. 46 establishes the rules for the registration and expert examination of medical devices. The EAEU framework provides for a registration certificate that is effective within the Union.

Roszdravnadzor's own information confirms that registration of medical devices within the EAEU is carried out under Decision No. 46. Its current EAEU registration service also identifies manufacturers and their authorized representatives as applicants.

This means manufacturers entering Russia should consider both:

1. The common EAEU regulatory requirements, and
2. The Russian administrative procedures through Roszdravnadzor.

What Does the Draft Administrative Regulation Cover?

The proposed regulation provides a more structured description of the administrative service.

According to the draft, the service covers activities including registration of medical devices, changes to registration dossiers, issuance of duplicate registration certificates, agreement of expert conclusions for registered devices and cancellation of registration certificates.

For an initial registration, the proposed results include issuance of the medical device registration certificate and entry into the unified register of medical devices.

For certain post-registration procedures, the draft also describes how amended registration certificates and corresponding registry records would be handled.

This provides manufacturers with greater visibility into the administrative lifecycle surrounding an EAEU registration in Russia.

Who Can Apply?

The draft identifies the medical device manufacturer or its authorized representative as the applicant.

The applicant categories include manufacturers established as legal entities or individual entrepreneurs and authorized representatives meeting the relevant Russian requirements.

This makes the appointment and management of the authorized representative an important element of EAEU market-entry planning.

Manufacturers should ensure that:

• The authorized representative arrangement is properly documented
• Powers of representation are clearly defined
• Registration responsibilities are assigned
• Regulatory communications can be handled promptly
• The representative has access to current technical and regulatory information
• Changes to the manufacturer's documentation are communicated appropriately

Registration Dossier and Documentation

EAEU registration requires a substantial technical and regulatory dossier. The administrative draft references the documentation requirements established by Decision No. 46 and related EAEU instruments.

Companies should therefore prepare documentation covering applicable areas such as:

• Product identification
• Intended purpose
• Medical device classification
• Technical documentation
• Safety and performance evidence
• Clinical or clinical-laboratory evidence where applicable
• Labeling and instructions for use
• Quality management system documentation
• Manufacturing information
• Test reports
• Existing approvals or certificates
• Authorized representative documentation

Roszdravnadzor's current guidance confirms that, where Russia is selected as the reference state, applicants submit the documentation specified under the relevant provisions of Decision No. 46.

Manufacturing Inspection and Quality Management

The draft also identifies assessment of manufacturing conditions and the manufacturer's quality management system as a necessary service associated with EAEU registration where applicable.

The assessment relates to compliance with the EAEU requirements for implementing, maintaining and evaluating medical device quality management systems according to potential application risk.

This means manufacturers should not treat registration documentation as an isolated regulatory exercise.

Before submission, companies should assess whether there:

• Quality management system
• Manufacturing processes
• Production sites
• Technical documentation
• Risk management activities
• Change-control procedures
• Post-market processes

are appropriately aligned with the EAEU requirements.

The EAEU framework continues to develop in this area. For example, Roszdravnadzor's regulatory materials now include the EEC Board Recommendation No. 6 of 7 April 2026 concerning methodological recommendations for medical device manufacturing inspections, while EEC Council Decision No. 43 of 27 April 2026 amended requirements relating to medical device quality management systems.

Administrative Timelines

One of the practical elements addressed by the draft is the expected administrative timeframe.

The proposed regulation indicates a maximum service period of 154 working days for registration and examination, while certain other procedures have different timelines. The draft indicates up to 90 working days for changes to a registration dossier and 5 working days for issuance of a duplicate registration certificate.

These timelines should be incorporated into market-entry planning rather than treated as a substitute for overall regulatory project planning.

Actual project duration can depend on dossier completeness, expert examination, requests for additional information, inspections and other procedural steps.

Digital and Administrative Infrastructure

The draft also identifies several information systems involved in the provision of the service, including the Unified Portal of State and Municipal Services, Russian interagency information systems and the integration gateway associated with the Russian national segment of the EAEU integrated information system.

This indicates a continued move toward a more structured administrative interface between Russian authorities and the wider EAEU regulatory infrastructure.

For manufacturers, maintaining accurate electronic documentation and ensuring consistency between submitted information and supporting records will therefore remain important.

What This Means for Medical Device Companies

The proposed regulation is particularly relevant to companies that are:

• Planning first-time EAEU registration
• Selecting Russia as a reference state
• Working through a Russian authorized representative
• Preparing registration dossiers under Decision No. 46
• Updating an existing EAEU registration
• Preparing manufacturing inspections
• Managing post-registration changes
• Expanding into the wider EAEU market

Companies should avoid viewing the development simply as an administrative formality.

The clearer Russian procedure can affect regulatory planning, documentation readiness, project timelines and communication between manufacturers, authorized representatives and regulatory experts.

2026 EAEU Medical Device Registration Readiness Checklist

Key Considerations for Manufacturers and Authorized Representatives

Manufacturers should begin by mapping their current product portfolio against the EAEU registration requirements.

Attention should be given to products that were previously managed primarily through Russian national registration strategies or transitional arrangements.

Companies should determine:

• Whether the product is already registered under the EAEU system
• Whether an existing registration requires modification
• Whether a new EAEU application is required
• Which entity will act as applicant
• Whether an authorized representative arrangement remains appropriate
• Which evidence is available and current
• Whether manufacturing inspection requirements apply
• Whether labeling and technical documentation require updates

Authorized representatives should also establish internal procedures for receiving regulatory correspondence, managing requests for information and coordinating dossier updates with manufacturers.

Frequently Asked Questions

1. Does the 2026 draft create a new Russian medical device registration pathway?

No. The draft formalizes the Russian administrative provision of the EAEU registration service. The underlying registration framework remains based on EAEU rules, including Decision No. 46.

2. Who provides the registration service in Russia?

The draft identifies Roszdravnadzor as the authority providing the state service.

3. Who can apply?

The draft identifies the medical device manufacturer or its authorized representative as the applicant.

4. What is Decision No. 46?

Decision No. 46 establishes the EAEU rules for registration and expert examination of the safety, quality and effectiveness of medical devices.

5. Does the EAEU registration certificate apply only in Russia?

No. Under the EAEU framework, the medical device registration certificate is effective within the Union.

6. What should companies do now?

Manufacturers should review their EAEU registration strategy, applicant arrangements, technical documentation, QMS readiness, manufacturing inspection requirements and regulatory timelines.

Conclusion

Russia's 20 April 2026 draft administrative regulation represents a further step toward formalizing how EAEU medical device registration services are administered by Roszdravnadzor.

The development does not replace the EAEU registration framework. Instead, it provides greater administrative structure around the Russian authority's implementation of the registration service under EEC Decision No. 46.

For manufacturers and authorized representatives, the practical priority should be to ensure that regulatory strategy, technical documentation, quality systems, manufacturing readiness and administrative responsibilities are aligned before submission.

As the EAEU medical device framework continues to evolve, companies planning market access through Russia should monitor both EAEU-level regulatory developments and Russian administrative implementation.

Early preparation can help organizations identify documentation gaps, clarify responsibilities and build realistic timelines for EAEU market entry.

How Maven Regulatory Solutions Can Help

Maven Regulatory Solutions can support medical device companies with:

• EAEU medical device regulatory assessments
• Russia medical device registration strategy
• Roszdravnadzor regulatory assessments
• EAEU registration dossier reviews
• Authorized representative assessments
• Medical device classification reviews
• Technical documentation gap assessments
• QMS and manufacturing inspection readiness
• Clinical and safety evidence assessments
• Registration change assessments
• Regulatory submission planning
• EAEU market-entry strategy
• Regulatory intelligence and monitoring

Our approach helps manufacturers and regulatory teams prepare for evolving Russian and EAEU medical device requirements while maintaining a structured, practical approach to market access.